Capital Investment Services of America Inc. lessened its position in Johnson & Johnson (NYSE:JNJ) by 3.6% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,954 shares of the company’s stock after selling 450 shares during the period. Capital Investment Services of America Inc.’s holdings in Johnson & Johnson were worth $1,581,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of JNJ. Lenox Wealth Advisors Inc. increased its holdings in Johnson & Johnson by 0.7% in the 1st quarter. Lenox Wealth Advisors Inc. now owns 871 shares of the company’s stock worth $108,000 after purchasing an additional 6 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. increased its holdings in Johnson & Johnson by 241.0% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,190 shares of the company’s stock worth $149,000 after purchasing an additional 841 shares in the last quarter. Ullmann Financial Group Inc. acquired a new position in Johnson & Johnson in the 1st quarter worth about $186,000. Taylor Wealth Management Partners increased its holdings in Johnson & Johnson by 19.8% in the 1st quarter. Taylor Wealth Management Partners now owns 1,510 shares of the company’s stock worth $188,000 after purchasing an additional 250 shares in the last quarter. Finally, Foundation Resource Management Inc. acquired a new position in Johnson & Johnson in the 1st quarter worth about $204,000. 65.90% of the stock is owned by institutional investors and hedge funds.

In other Johnson & Johnson news, VP Paulus Stoffels sold 102,692 shares of the company’s stock in a transaction that occurred on Monday, July 24th. The stock was sold at an average price of $133.14, for a total transaction of $13,672,412.88. Following the transaction, the vice president now owns 230,342 shares in the company, valued at approximately $30,667,733.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Dominic J. Caruso sold 82,591 shares of the company’s stock in a transaction that occurred on Thursday, July 20th. The stock was sold at an average price of $136.72, for a total value of $11,291,841.52. Following the transaction, the vice president now owns 226,693 shares in the company, valued at approximately $30,993,466.96. The disclosure for this sale can be found here. 0.19% of the stock is currently owned by corporate insiders.

Johnson & Johnson (NYSE JNJ) traded down 0.25% during midday trading on Tuesday, reaching $135.04. The company had a trading volume of 1,781,902 shares. The company has a 50-day moving average price of $132.72 and a 200-day moving average price of $129.35. Johnson & Johnson has a one year low of $109.32 and a one year high of $137.08. The stock has a market capitalization of $362.45 billion, a price-to-earnings ratio of 22.85 and a beta of 0.79.

Johnson & Johnson (NYSE:JNJ) last posted its earnings results on Tuesday, July 18th. The company reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.79 by $0.04. Johnson & Johnson had a return on equity of 26.76% and a net margin of 22.52%. The firm had revenue of $18.84 billion for the quarter, compared to the consensus estimate of $18.94 billion. During the same quarter in the prior year, the business earned $1.74 EPS. The business’s revenue for the quarter was up 1.9% on a year-over-year basis. On average, equities analysts expect that Johnson & Johnson will post $7.18 earnings per share for the current year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Tuesday, August 29th were issued a dividend of $0.84 per share. The ex-dividend date of this dividend was Friday, August 25th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.48%. Johnson & Johnson’s dividend payout ratio (DPR) is 56.76%.

A number of equities analysts have issued reports on JNJ shares. BidaskClub raised Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 17th. Royal Bank Of Canada reissued a “buy” rating and issued a $128.00 price target on shares of Johnson & Johnson in a research note on Thursday, June 15th. Atlantic Securities cut Johnson & Johnson from a “neutral” rating to an “underweight” rating and set a $113.00 price target for the company. in a research note on Friday, July 21st. Jefferies Group LLC reissued a “hold” rating and issued a $145.00 price target (up previously from $140.00) on shares of Johnson & Johnson in a research note on Friday, July 14th. Finally, Morgan Stanley increased their price target on Johnson & Johnson from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Wednesday, July 5th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have given a buy rating to the company. Johnson & Johnson has an average rating of “Hold” and an average price target of $134.50.

WARNING: This piece of content was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of US and international copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/19/johnson-johnson-jnj-position-decreased-by-capital-investment-services-of-america-inc.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Stock Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related stocks with our FREE daily email newsletter.